Schedule 13G ownership disclosure

VERTEX PHARMACEUTICALS INC COM

Security class unavailable · CUSIP: 92532F100

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,863,986
Percent of class
6.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-16-001092
Form type
SC 13G/A
Filer
VERTEX PHARMACEUTICALS INC / MA
CIK
CIK 875320
Filed
Feb 11, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub